On Thursday, Shares of Fiat Chrysler Automobiles N.V. (NYSE:FCAU), lost -1.09% to $14.56.
Fiat Chrysler Automobiles has market worth of $18.63B while 1.28B shares were outstanding. The company offered net profit margin of 1.00% while its gross profit margin was 13.50%. ROE was recorded as 7.30% while beta factor was 2.05.
Fiat Chrysler Automobiles N.V., an automotive group, designs, engineers, manufactures, distributes, and sells vehicles and components. It offers passenger cars, light trucks, and light commercial vehicles under the Abarth, Alfa Romeo, Chrysler, Dodge, Fiat, Fiat Professional, Jeep, Lancia, and Ram brand names, in addition to after-sales services and parts under the Mopar brand name.
Shares of Barrick Gold Corporation (NYSE:ABX), inclined 1.69% to $7.82, during its last trading session.
Barrick Gold Corporation, will improvement its focus on productivity and efficiency gains in 2016 to further improve its balance sheet, the worlds biggest gold producer said on Thursday, according to Reuters.
Barrick, which has the highest debt of any gold miner, began 2015 with a $13.1 billion in debt, which it had whittled to $11.2 billion as of Wednesday.
The Toronto-based company plans to put about $1 billion from the sale of its Zaldivar copper mine toward debt, with free cash flow used to reach its $3 billion debt reduction target for 2015.
And there are no plans to ease off, Barrick told analysts on Thursday. Reuters Reports
Barrick Gold Corporation produces and sells gold and copper. The company is also involved in exploration and mine development activities. It conducts mining, development and exploration, and other activities in various countries, counting the United States, Canada, Australia, Argentina, Chile, Peru, the Dominican Republic, Papua New Guinea, Tanzania, Zambia, and Saudi Arabia.
Finally, Shares of Endo International plc (NASDAQ:ENDP), ended its last trade with -0.84% loss, and closed at $60.38.
Endo International, has beta value of 1.10. The company has the market capitalization of $13.67B. Return on assets ratio of the company was -4.90% while its return on equity ratio was -16.70%. ATR value of company was 5.61 while stock volatility for week was 9.41% while for month was 8.47%. Debt to equity ratio of the company was 0.88 and its current ratio was 2.20.
Endo International plc, a specialty healthcare company, focuses on branded and generic pharmaceuticals and devices worldwide. It operates through four segments: U.S. Branded Pharmaceuticals, U.S. Generic Pharmaceuticals, Devices, and International Pharmaceuticals. The U.S. Branded Pharmaceuticals segment provides various branded prescription products, counting Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Fortesta Gel, Supprelin LA, Valstar, Vantas, Sumavel DosePro, Aveed, and Natesto to treat and manage pain and conditions in urology, endocrinology, and oncology.
This article is published by www.stocksnewswire.com. The content included in this article is just for informational purposes only. Stocksnewswire.com takes sensible consideration to ensure that the data given in this article is up to date and accurate. The news, prices, opinions, research, analysis, and other information published in this article are obtained from sources believed to be reliable.
Neither Stocksnewswire.com nor any of Stocksnewswire.com partners make any representation or guarantee as to the fulfillment or precision of the information contained in this article.
Investors must consult their own additional due diligence with any potential investment or highlighted company before making any decision on behalf of information offered by Stocksnewswire.com.
Information contained in this article may contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long-term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward-looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.